Virtus ETF Advisers LLC - ESPERION THERAPEUTICS INC NE ownership

ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 154 filers reported holding ESPERION THERAPEUTICS INC NE in Q3 2019. The put-call ratio across all filers is 1.02 and the average weighting 0.2%.

Quarter-by-quarter ownership
Virtus ETF Advisers LLC ownership history of ESPERION THERAPEUTICS INC NE
ValueSharesWeighting
Q3 2021$214,000
-47.8%
17,773
-8.4%
0.09%
-44.4%
Q2 2021$410,000
-30.9%
19,398
-8.3%
0.17%
-32.4%
Q1 2021$593,000
+10.8%
21,157
+2.8%
0.25%
+12.6%
Q4 2020$535,000
+7.0%
20,576
+53.1%
0.22%
-15.3%
Q3 2020$500,000
-20.9%
13,442
+9.2%
0.26%
-12.4%
Q2 2020$632,000
+177.2%
12,310
+70.1%
0.30%
+218.1%
Q1 2020$228,000
-53.9%
7,235
-12.8%
0.09%
+16.0%
Q4 2019$495,000
+161.9%
8,298
+61.3%
0.08%
+113.2%
Q3 2019$189,000
-25.3%
5,144
-5.3%
0.04%
-28.3%
Q2 2019$253,000
+15.0%
5,430
-1.0%
0.05%
-88.7%
Q1 2019$220,000
-23.9%
5,483
-12.7%
0.47%
+855.1%
Q4 2018$289,000
-42.3%
6,279
-44.4%
0.05%
-5.8%
Q3 2018$501,000
-34.4%
11,297
-42.0%
0.05%
-92.3%
Q2 2018$764,000
-18.4%
19,484
+50.5%
0.68%
-16.9%
Q1 2018$936,000
+134.6%
12,943
+113.7%
0.81%
+62.1%
Q4 2017$399,000
-14.0%
6,057
-34.5%
0.50%
+695.2%
Q3 2017$464,000
+19.3%
9,250
+10.1%
0.06%
+8.6%
Q2 2017$389,000
-51.6%
8,404
-63.1%
0.06%
-59.4%
Q1 2017$804,000
+211.6%
22,773
+10.6%
0.14%
+85.7%
Q4 2016$258,000
+20.0%
20,590
+32.5%
0.08%
-26.0%
Q3 2016$215,000
+39.6%
15,5400.0%0.10%
-8.8%
Q2 2016$154,000
-17.2%
15,540
+41.1%
0.11%
-55.5%
Q1 2016$186,00011,0110.26%
Other shareholders
ESPERION THERAPEUTICS INC NE shareholders Q3 2019
NameSharesValueWeighting ↓
Meditor Group Ltd 4,468,835$20,735,0008.65%
Altium Capital Management LP 2,496,524$11,584,0003.88%
Deep Track Capital, LP 6,000,000$27,840,0001.78%
Paradigm Biocapital Advisors LP 1,157,246$5,370,0001.42%
Monaco Asset Management SAM 419,262$1,945,0000.77%
Rhenman & Partners Asset Management AB 981,582$4,555,0000.45%
PLATINUM INVESTMENT MANAGEMENT LTD 2,713,176$12,589,0000.39%
Bellevue Group AG 4,299,164$19,948,0000.23%
WASATCH ADVISORS LP 8,147,380$37,804,0000.19%
Telemetry Investments, L.L.C. 17,500$81,0000.13%
View complete list of ESPERION THERAPEUTICS INC NE shareholders